Antibiotic Treatment for Bacterial Gastroenteritis in Children

Introduction to Antibiotic Use

The American Academy of Pediatrics and the Infectious Diseases Society of America recommend that most children with bacterial gastroenteritis do not require antibiotics, but when antibiotics are indicated, azithromycin is the preferred first-line agent for Shigella and Campylobacter infections, while ceftriaxone is recommended for severe Salmonella infections 1, 2

The Infectious Diseases Society of America recommends avoiding empiric treatment in immunocompetent children with watery diarrhea without specific risk factors 1
The Centers for Disease Control and Prevention advise that STEC O157 and Shiga toxin-producing E. coli infections should not receive antibiotics due to increased risk of hemolytic uremic syndrome 1
The American Academy of Pediatrics suggests that specific clinical scenarios requiring antibiotic treatment include infants < 3 months of age with suspected bacterial etiology, severe dysentery syndrome, recent international travel with fever ≥38.5°C and/or signs of sepsis, and immunocompromised patients with severe illness and bloody diarrhea 1
The Infectious Diseases Society of America recommends that high-risk patients with Salmonella, such as infants <3 months, immunocompromised, sickle cell disease, or severe systemic illness, should receive antibiotics 2

The Infectious Diseases Society of America recommends azithromycin as the first-line treatment for Shigellosis, due to rising resistance to fluoroquinolones and trimethoprim-sulfamethoxazole 3, 4
The American Academy of Pediatrics suggests that azithromycin demonstrates shorter duration of diarrhea compared to ciprofloxacin and erythromycin 3, 4
The Infectious Diseases Society of America recommends ceftriaxone as the first-line treatment for severe Salmonellosis, with ciprofloxacin as an alternative 2
The Centers for Disease Control and Prevention advise that azithromycin is the first-line treatment for Campylobacter infections, particularly when given early in the illness 2
The World Health Organization recommends azithromycin as the first-line treatment for Cholera, with doxycycline or ciprofloxacin as alternatives 3, 4

The Infectious Diseases Society of America recommends azithromycin as the preferred empiric treatment for severe cases requiring empiric therapy before identification, based on local susceptibility and travel history 1
The American Academy of Pediatrics suggests that ciprofloxacin is an alternative empiric treatment, but should be avoided in children <18 years if alternatives are available 2
The Infectious Diseases Society of America recommends third-generation cephalosporin, such as ceftriaxone or cefotaxime, for infants <3 months 1
The American Academy of Pediatrics advises that ciprofloxacin plus metronidazole is an empiric treatment option for severe sepsis or high-risk patients, with aminoglycoside-based regimen as an alternative 2

The American Academy of Pediatrics recommends that fluoroquinolones should be avoided in children <18 years and pregnant women when alternatives exist due to musculoskeletal concerns 2
The Infectious Diseases Society of America warns that antibiotic resistance is a major global concern in Salmonella, Shigella, and Campylobacter, limiting therapeutic options 2
The Centers for Disease Control and Prevention advise that multiplex PCR detection does not equal causation, and presence of potential pathogens may represent colonization rather than active infection 1